 | Up a level |
Deubzer, H., Fabian, J., Opitz, D., Althoff, K., Lodrini, M., Astrahantseff, K., Hero, B., Volland, R., Beckers, A., De Preter, K., Patil, N., Abba, M., Wuenchel, J., Thole, T., Hu, J., Schweitzer, L., Mechtersheimer, G., Carter, D., Cheung, B., Popanda, O., von Deimling, A., Henrich, K. O., Westermann, F., Schwab, M., Koster, J., Versteeg, R., Marshall, G., Speleman, F., Zoeller, M., Allgayer, H., Fischer, M., Berthold, F., Kulozik, A., Witt, O., Schulte, J. and Eggert, A. (2015). MYCN TRANSCRIPTIONALLY REPRESSES CD9 TO TRIGGER AN INVASION-METASTASIS CASCADE IN NEUROBLASTOMA. Pediatr. Blood Cancer, 62. S. S150 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Haber, M., Murray, J., Gamble, L., Carnegie-Clark, A., Webber, H., Ruhle, M., Carter, D., Oberthur, A., Fischer, M., Ziegler, D., Marshall, G. M., Gurova, K., Burkhart, C., Purmal, A., Gudkov, A. V. and Norris, M. D. (2014). CBL0137, a novel NFkB suppressor and p53 activator, is highly effective in pre-clinical models of neuroblastoma. Eur. J. Cancer, 50. S. 135 - 136. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852